Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and...

Area of Science:

• Molecular biology
• Structural biology
• Pharmacology

Background:

• Epothilone B is a potent anti-cancer drug targeting tubulin.
• Drug resistance can arise from mutations in target proteins, affecting drug efficacy.
• Understanding these resistance mechanisms is crucial for developing new therapeutics.

Purpose of the Study:

• To investigate the structural and dynamic effects of specific tubulin mutations on epothilone B binding.
• To identify molecular factors contributing to epothilone B resistance.
• To provide insights for the rational design of novel anti-cancer agents.

Main Methods:

• Molecular modeling techniques were employed.
• Analysis of wild-type and mutated tubulin-epothilone B complexes.
• Investigation of protein conformation, ligand binding pose, and interaction networks.

Main Results:

• Tubulin mutations significantly alter protein conformation in ligand-binding and microtubule assembly regions.
• Mutations cause drastic changes in epothilone B binding pose and interaction networks.
• A looser ligand binding and decreased polar contacts were observed in mutated tubulin, explaining reduced drug activity.

Conclusions:

• The study explains the loss of epothilone B activity against cancer cells with specific tubulin mutations.
• Findings elucidate the atomic basis of epothilone activity and drug resistance.
• Results can guide the development of more potent tubulin-binding anti-cancer drugs.